HRP20110572T1 - Priprema 3-[(1r,2r)-3-(dimetilamino)-1etil-2-metilpropil]fenola - Google Patents

Priprema 3-[(1r,2r)-3-(dimetilamino)-1etil-2-metilpropil]fenola Download PDF

Info

Publication number
HRP20110572T1
HRP20110572T1 HR20110572T HRP20110572T HRP20110572T1 HR P20110572 T1 HRP20110572 T1 HR P20110572T1 HR 20110572 T HR20110572 T HR 20110572T HR P20110572 T HRP20110572 T HR P20110572T HR P20110572 T1 HRP20110572 T1 HR P20110572T1
Authority
HR
Croatia
Prior art keywords
anhydride
formula
compound
chloride
vii
Prior art date
Application number
HR20110572T
Other languages
English (en)
Croatian (hr)
Inventor
Hell Wolfgang
Original Assignee
Grnenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grnenthal Gmbh filed Critical Grnenthal Gmbh
Publication of HRP20110572T1 publication Critical patent/HRP20110572T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/20Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C219/22Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HR20110572T 2006-07-24 2011-08-02 Priprema 3-[(1r,2r)-3-(dimetilamino)-1etil-2-metilpropil]fenola HRP20110572T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06015317 2006-07-24
PCT/EP2007/006514 WO2008012046A1 (en) 2006-07-24 2007-07-23 Preparation of 3-[(1r,2r)-3-(dimethylamino)-1ethyl-2-methylpropyl]phenol

Publications (1)

Publication Number Publication Date
HRP20110572T1 true HRP20110572T1 (hr) 2011-09-30

Family

ID=37492362

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110572T HRP20110572T1 (hr) 2006-07-24 2011-08-02 Priprema 3-[(1r,2r)-3-(dimetilamino)-1etil-2-metilpropil]fenola

Country Status (24)

Country Link
US (1) US8263809B2 (no)
EP (1) EP2049464B1 (no)
JP (1) JP5357756B2 (no)
KR (1) KR101433685B1 (no)
CN (1) CN101495446B (no)
AT (1) ATE515491T1 (no)
AU (1) AU2007278463B2 (no)
BR (1) BRPI0714648B8 (no)
CA (1) CA2658648C (no)
CY (1) CY1111829T1 (no)
DK (1) DK2049464T3 (no)
ES (1) ES2366390T3 (no)
HK (1) HK1130247A1 (no)
HR (1) HRP20110572T1 (no)
IL (1) IL196626A (no)
MX (1) MX2008016380A (no)
NO (1) NO341683B1 (no)
NZ (1) NZ573906A (no)
PL (1) PL2049464T3 (no)
RU (1) RU2463290C2 (no)
SI (1) SI2049464T1 (no)
TW (1) TWI401237B (no)
WO (1) WO2008012046A1 (no)
ZA (1) ZA200901279B (no)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2656696C (en) * 2006-07-24 2013-06-11 Janssen Pharmaceutica N.V. Preparation of (2r,3r)-3-(3-methoxyphenyl)-n,n,2-trimethylpentanamine
KR20110081852A (ko) 2008-10-17 2011-07-14 파마코포어, 인크. 페놀성 오피오이드를 약독화시켜 방출하는 약제학적 조성물
CN102002065B (zh) * 2009-09-02 2014-09-10 上海特化医药科技有限公司 他喷他多的制备方法及其中间体
US8288592B2 (en) * 2009-09-22 2012-10-16 Actavis Group Ptc Ehf Solid state forms of tapentadol salts
IT1397189B1 (it) * 2009-12-01 2013-01-04 Archimica Srl Nuovo processo per la preparazione di tapentadol e suoi intermedi.
WO2011080756A1 (en) * 2009-12-29 2011-07-07 Ind-Swift Laboratories Limited Process for the preparation of 1-phenyl-3-dimethylaminopropane derivatives
US20130096346A1 (en) 2010-03-05 2013-04-18 Actavis Group Ptc Ehf Resolution methods for isolating desired enantiomers of tapentadol intermediates and use thereof for the preparation of tapentadol
AU2011241897A1 (en) 2010-04-05 2012-09-27 Actavis Group Ptc Ehf Novel process for preparing highly pure tapentadol or a pharmaceutically acceptable salt thereof
US20110262355A1 (en) 2010-04-21 2011-10-27 Jenkins Thomas E Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof
ES2710617T3 (es) 2010-04-21 2019-04-26 Signature Therapeutics Inc Composiciones que comprenden profármacos de anfetamina escindibles enzimáticamente e inhibidores de los mismos
WO2011133178A1 (en) 2010-04-21 2011-10-27 Pharmacofore, Inc Compositions comprising enzyme-cleavable phenol-modified tapentadol prodrug
ITMI20100924A1 (it) * 2010-05-21 2011-11-22 Fidia Farmaceutici Nuovo metodo di sintesi delle due forme enantiomeriche del tapentadol
US8669399B2 (en) 2010-06-15 2014-03-11 Grünenthal GmbH Process for preparing substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds
IT1401109B1 (it) * 2010-07-02 2013-07-12 Archimica Srl Nuovo processo per la preparazione di tapentadol e suoi intermedi.
ES2860676T3 (es) * 2010-07-23 2021-10-05 Gruenenthal Gmbh Sales o cocristales de 3- (3-dimetilamino-1-etil-2-metil-propil) -fenol
WO2012023147A1 (en) 2010-08-16 2012-02-23 Indoco Remedies Limited Process for the preparation of tapentadol
US8552219B2 (en) 2010-09-20 2013-10-08 Ind-Swift Laboratories Limited Process for preparing L-phenyl-3-dimethylaminopropane derivative
HUP1300623A2 (en) * 2010-12-30 2014-03-28 Zentiva Ks O-substituted (2r,3r)-3-(3-hidroxiphenil)-2-metyil-4-pentenoic acids and a method of obtaining the same
EP2663187B1 (en) 2011-01-11 2016-06-01 Signature Therapeutics, Inc. Compositions comprising enzyme-cleavable oxycodone prodrug
US20130296608A1 (en) 2011-01-27 2013-11-07 Symed Labs Limited Novel stereospecific synthesis of (-) (2s, 3s)-1-dimethylamino-3-(3-methoxyphenyl)-2-methyl pentan-3-ol
CN102617501A (zh) 2011-01-31 2012-08-01 中国科学院上海药物研究所 取代正戊酰胺类化合物、其制备方法及用途
MX351584B (es) * 2011-03-04 2017-10-20 Gruenenthal Gmbh Formulacion farmaceutica acuosa de tapentadol para administracion oral.
RU2608305C2 (ru) 2011-03-09 2017-01-17 Сигничер Терапьютикс, Инк. Пролекарства действующих веществ гетероциклическими линкерами
WO2012146978A2 (en) 2011-04-28 2012-11-01 Actavis Group Ptc Ehf A novel process for the preparation of tapentadol or a pharmaceutically acceptable salt thereof
WO2013105109A1 (en) 2011-11-09 2013-07-18 Indoco Remedies Limited Process for the preparation of tapentadol
WO2013090161A1 (en) 2011-12-12 2013-06-20 Boehringer Ingelheim International Gmbh Stereoselective synthesis of tapentadol and its salts
WO2013120466A1 (en) 2012-02-17 2013-08-22 Zentiva, K.S. A new solid form of tapentadol and a method of its preparation
EP2674414A1 (en) 2012-06-15 2013-12-18 Siegfried AG Method for the preparation of 1-aryl-1-alkyl-3-dialkylaminopropane compounds
CN103159633B (zh) * 2012-07-06 2015-08-12 江苏恩华药业股份有限公司 他喷他多的制备方法及用于制备他喷他多的化合物
CN102924303B (zh) * 2012-10-31 2013-11-20 合肥市新星医药化工有限公司 盐酸他喷他多晶型c及其制备方法和应用
WO2014141296A2 (en) * 2013-03-09 2014-09-18 Ind-Swift Laboratories Limited Process for the preparation of tapentadol via novel intermediate
WO2015075744A1 (en) * 2013-11-01 2015-05-28 Sun Pharma Advanced Research Company Novel intermediate of tapentadol
CN103553940A (zh) * 2013-11-07 2014-02-05 南京艾德凯腾生物医药有限责任公司 一种新晶型盐酸他喷他多的制备方法
WO2015075678A1 (en) 2013-11-21 2015-05-28 Unimark Remedies Ltd. A novel process for the preparation of 1-phenyl-3-aminopropane derivatives
WO2015091068A1 (en) 2013-12-16 2015-06-25 Farma Grs, D.O.O. Crystalline forms of tapentadol intermediate
CZ307492B6 (cs) 2014-02-04 2018-10-17 Zentiva, K.S. Pevná forma maleátu tapentadolu a způsob její přípravy
ES2940904T3 (es) 2014-07-10 2023-05-12 SpecGx LLC Procedimiento para preparar fenilalcanos sustituidos
EP3995492B1 (en) 2015-07-10 2024-05-29 SpecGx LLC A two-step process for preparing 3-substituted phenylalkylamines
SK812017A3 (sk) 2017-08-18 2019-03-01 Saneca Pharmaceuticals A. S. Spôsob prípravy tapentadolu a jeho medziproduktov
EP4116288A1 (en) 2021-07-08 2023-01-11 KRKA, d.d., Novo mesto Racemization of (s) and/or (r)-3-(dimethylamino)-1-(3-methoxyphenyl)-2-methylpropan-1- one and its mixtures

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
JP4202327B2 (ja) * 1996-04-09 2008-12-24 ヤマサ醤油株式会社 1−(2−デオキシ−2−フルオロ−4−チオ−β−D−アラビノフラノシル)シトシン
DE19805370A1 (de) * 1997-03-14 1998-09-17 Gruenenthal Gmbh Substituierte Aminoverbindungen und ihre Verwendung als analgetisch wirksame Substanzen
US6399828B1 (en) * 2001-10-29 2002-06-04 Boehringer Ingelheim Chemicals, Inc. Preparation of amphetamines from phenylpropanolamines
DE10326097A1 (de) 2003-06-06 2005-01-05 Grünenthal GmbH Verfahren zur Herstellung von Dimethyl-(3-aryl-butyl)-aminverbindungen
DE10328316A1 (de) 2003-06-23 2005-01-20 Grünenthal GmbH Verfahren zur Herstellung von Dimethyl-(3-aryl-buthyl)-aminverbindungen als pharmazeutische Wirkstoffe
CA2656696C (en) * 2006-07-24 2013-06-11 Janssen Pharmaceutica N.V. Preparation of (2r,3r)-3-(3-methoxyphenyl)-n,n,2-trimethylpentanamine

Also Published As

Publication number Publication date
CA2658648A1 (en) 2008-01-31
JP5357756B2 (ja) 2013-12-04
TW200815317A (en) 2008-04-01
DK2049464T3 (da) 2011-08-15
WO2008012046A1 (en) 2008-01-31
NZ573906A (en) 2011-04-29
TWI401237B (zh) 2013-07-11
PL2049464T3 (pl) 2011-11-30
SI2049464T1 (sl) 2011-10-28
HK1130247A1 (no) 2009-12-24
US20090326271A1 (en) 2009-12-31
RU2463290C2 (ru) 2012-10-10
RU2009106169A (ru) 2010-08-27
KR20090035003A (ko) 2009-04-08
BRPI0714648A2 (pt) 2013-05-07
AU2007278463B2 (en) 2011-11-24
ES2366390T3 (es) 2011-10-19
ATE515491T1 (de) 2011-07-15
KR101433685B1 (ko) 2014-08-25
JP2009544637A (ja) 2009-12-17
EP2049464B1 (en) 2011-07-06
NO20090691L (no) 2009-02-23
EP2049464A1 (en) 2009-04-22
IL196626A0 (en) 2009-11-18
BRPI0714648B8 (pt) 2021-05-25
BRPI0714648B1 (pt) 2021-02-02
CA2658648C (en) 2014-02-25
AU2007278463A1 (en) 2008-01-31
US8263809B2 (en) 2012-09-11
CN101495446B (zh) 2012-12-05
CN101495446A (zh) 2009-07-29
NO341683B1 (no) 2017-12-18
CY1111829T1 (el) 2015-10-07
MX2008016380A (es) 2009-01-30
IL196626A (en) 2013-07-31
ZA200901279B (en) 2010-02-24

Similar Documents

Publication Publication Date Title
HRP20110572T1 (hr) Priprema 3-[(1r,2r)-3-(dimetilamino)-1etil-2-metilpropil]fenola
HRP20100197T1 (hr) Dobivanje (2r, 3r)-3-(3-metoksifenil)-n,n,2-trimetilpentanamina
Padrón et al. Enantiospecific synthesis of α-amino acid semialdehydes: a key step for the synthesis of unnatural unsaturated and saturated α-amino acids
US7553831B2 (en) Compounds to treat Alzheimer's disease
US20060106256A1 (en) Substituted hydroxyethylamines
SK287399B6 (sk) Mono- alebo disubstituovaná kyselina 3-propyl-gama-aminomaslová, jej použitie na výrobu liečiva a farmaceutický prostriedok s jej obsahom
JP2011507941A5 (no)
Rubio-Pérez et al. One-pot stibine modified Co2 (CO) 8 catalyzed reductive N-alkylation of primary amides with carbonyl compounds
WO2014005546A1 (zh) 他喷他多的制备方法及用于制备他喷他多的化合物
JP2010513492A (ja) 3−(アミノ)−3−(シクロブチルメチル)−2−(ヒドロキシ)−プロピオンアミド塩酸塩の調製
JP4721518B2 (ja) 5−アミノ−イソフタルアミドの製造方法
Kim et al. Asymmetric syntheses of N-substituted α-amino esters via dynamic kinetic resolution of α-haloacyl diacetone-d-glucose
Aldea et al. Ruthenium clay catalyzed reduction of α-iminoesters and α-iminoketones, and the reductive amination of α-ketoesters
JPH07291904A (ja) 天然型のスフィンゴシン及びその類縁化合物の製造法
JP2010031004A (ja) 新規イミダゾール誘導体及びその製造方法並びに該イミダゾール誘導体を利用したヒスチジンアミド誘導体の製造方法
JP2005132746A (ja) ピリジルピロリジンジカルボン酸アミド誘導体
JP2003212874A (ja) イソキヌクリジン誘導体の製造方法
JPH0987249A (ja) フタルイミド誘導体
JP2005097202A (ja) 触媒的不斉水素添加による光学活性ラクタム誘導体の製造方法
JPH10152459A (ja) 1,3−ジアミノ−4−フェニル−2−ブタノール誘導体の製造方法、並びにその製造中間体及びその製造方法